BMP6 and FREM1 mutations have so far been reported in single BCP ALL cases only (https://cancer.sanger.ac.uk/cosmic), whereas CBL, JAK2, and SH2B3 mutations are recurrent in BCP ALL. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.